pfizer - Search News

News

Pfizer, Q2

Pfizer's Turnaround Has Truly Started (Earnings Update)

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE stock is a Buy.

Houston Chronicle · 2d

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

Zacks.com on MSN · 1d

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.

Pfizer Raises Profit Outlook

Reuters on MSN · 1d

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

The Wall Street Journal on MSN · 1d

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

MarketWatch on MSN · 2d

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

17h

Pfizer Q2: Dividends Speak Louder Than EPS

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

1don MSN

Why Shares of Pfizer Soared Today

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

23h

Pfizer Pops Despite Looming Pharma Tariffs

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

5don MSN

Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

1don MSN

1 Reason to Buy Pfizer (PFE) Stock

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...

Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer

Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...

5don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

4don MSN

The 3 Things That Matter for Pfizer Now

Pfizer's oncology pipeline looks promising. The company's newer approvals could make significant progress. And its efforts to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Pfizer, Q2

Pfizer Raises Profit Outlook

Related topics